Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
4(29%)
Results Posted
83%(5 trials)
Terminated
2(14%)

Phase Distribution

Ph not_applicable
14
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution14 total trials
N/ANon-phased studies
14(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(4)
Completed(6)
Terminated(3)
Other(1)

Detailed Status

Completed6
Recruiting4
Terminated2
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
75.0%
Most Advanced
N/A

Trials by Phase

N/A14 (100.0%)

Trials by Status

terminated214%
completed643%
recruiting429%
withdrawn17%
unknown17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
OTHER
Total Trials
14